NFKB1 and Parkinson disease: Consequently, a considerable increase in the activation of p65/RelA has been observed in dopaminergic neurons of PD patients (Hunot et al., 1997), while administration of NF-κB inhibitors have improved the pathological changes in a murine model of PD (Flood et al., 2011).